{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:16:54Z","timestamp":1790021814914,"version":"4.0.1"},"reference-count":144,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T00:00:00Z","timestamp":1675296000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ajp.2023.103480","type":"journal-article","created":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T07:24:34Z","timestamp":1674545074000},"page":"103480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Taiwan consensus on biological treatment of bipolar disorder during the acute, maintenance, and mixed phases: The 2022 update"],"prefix":"10.1016","volume":"82","author":[{"given":"Chih-Ming","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-See","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Kuang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Mei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2023.103480_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2009.05.005","article-title":"Maintenance treatment received by patients with bipolar I and II disorders--a naturalistic prospective study","volume":"121","author":"Arvilommi","year":"2010","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jad.2020.03.030","article-title":"Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis","volume":"269","author":"Bahji","year":"2020","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jcma.2013.06.013","article-title":"Taiwan consensus of pharmacological treatment for bipolar disorder","volume":"76","author":"Bai","year":"2013","journal-title":"J. Chin. Med Assoc."},{"key":"10.1016\/j.ajp.2023.103480_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/00004714-200304000-00005","article-title":"Acute dysphoric mania: treatment response to olanzapine versus placebo","volume":"23","author":"Baker","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1192\/bjp.185.6.472","article-title":"Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania","volume":"185","author":"Baker","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib6","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1007\/s40618-021-01600-w","article-title":"Role of thyroid hormone therapy in depressive disorders","volume":"44","author":"Bauer","year":"2021","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.ajp.2023.103480_bib7","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jad.2010.06.030","article-title":"Evaluation of the efficacy and safety of paliperidone extended-release in the treatment of acute mania: a randomized, double-blind, dose-response study","volume":"136","author":"Berwaerts","year":"2012","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib8","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jad.2009.11.008","article-title":"Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis","volume":"124","author":"Bond","year":"2010","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib9","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4088\/JCP.09m05482yel","article-title":"Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial","volume":"71","author":"Bowden","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1017\/S1461145708009735","article-title":"Olanzapine\/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression","volume":"12","author":"Brown","year":"2009","journal-title":"Int J. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group","volume":"60","author":"Calabrese","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib12","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4088\/JCP.14m09081","article-title":"Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study","volume":"76","author":"Calabrese","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.euroneuro.2017.06.013","article-title":"Lurasidone in combination with lithium or valproate for the maintenance treatment of bipolar I disorder","volume":"27","author":"Calabrese","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1055","article-title":"Therapeutic neuromodulation for bipolar disorder\u2014the case for biomarker-driven treatment development","volume":"4","author":"Camprodon","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.ajp.2023.103480_bib15","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4088\/JCP.16r10832","article-title":"Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis","volume":"78","author":"Carbon","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1399-5618.2011.00974.x","article-title":"Aripiprazole in combination with lamotrigine for the long-term treatment of patients with bipolar I disorder (manic or mixed): a randomized, multicenter, double-blind study (CN138-392)","volume":"14","author":"Carlson","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib17","doi-asserted-by":"crossref","first-page":"399","DOI":"10.5498\/wjp.v6.i4.399","article-title":"Treatment-adherence in bipolar disorder: a patient-centred approach","volume":"6","author":"Chakrabarti","year":"2016","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2019.04.009","article-title":"Neuroprotective effects of the second generation antipsychotics","volume":"208","author":"Chen","year":"2019","journal-title":"Schizophr. Res"},{"key":"10.1016\/j.ajp.2023.103480_bib19","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1017\/S003329171800332X","article-title":"Risk and coaggregation of major psychiatric disorders among first-degree relatives of patients with bipolar disorder: a nationwide population-based study","volume":"49","author":"Chen","year":"2019","journal-title":"Psychol. Med"},{"key":"10.1016\/j.ajp.2023.103480_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12991-016-0096-0","article-title":"Bipolar II compared with bipolar I disorder: baseline characteristics and treatment response to quetiapine in a pooled analysis of five placebo-controlled clinical trials of acute bipolar depression","volume":"15","author":"Datto","year":"2016","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/0006-3223(94)00194-8","article-title":"Mixed mania: apparent induction by a tricyclic antidepressant in five consecutively treated patients with bipolar depression","volume":"37","author":"Dilsaver","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jad.2012.06.014","article-title":"Diagnostic conversions from major depressive disorder into bipolar disorder in an outpatient setting: results of a retrospective chart review","volume":"144","author":"Dudek","year":"2013","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bdi.12238","article-title":"The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial","volume":"17","author":"Durgam","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1176\/appi.ajp.2015.15020164","article-title":"An 8-week randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of cariprazine in patients with bipolar I depression","volume":"173","author":"Durgam","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib25","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jad.2008.03.025","article-title":"Antidepressant-associated chronic irritable dysphoria (ACID) in STEP-BD patients","volume":"111","author":"El-Mallakh","year":"2008","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib26","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1517\/14656566.2010.490831","article-title":"Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder","volume":"11","author":"Fagiolini","year":"2010","journal-title":"Expert Opin. Pharm."},{"key":"10.1016\/j.ajp.2023.103480_bib27","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.jad.2020.07.109","article-title":"The concept and management of acute episodes of treatment-resistant bipolar disorder: a systematic review and exploratory meta-analysis of randomized controlled trials","volume":"276","author":"Fornaro","year":"2020","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib28","unstructured":"Frederick K.Goodwin, a.K.R.J., 2007. Manic-Depressive Illness, 2nd Ed: Bipolar Disorders and Recurrent Depression. 799\u2013801."},{"key":"10.1016\/j.ajp.2023.103480_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/JCP.0b013e318166c4d5","article-title":"Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review","volume":"28","author":"Gao","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1192\/bjp.bp.107.048504","article-title":"Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials","volume":"194","author":"Geddes","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib31","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1600-0447.2008.01257.x","article-title":"Long-term antidepressant treatment in bipolar disorder: meta-analyses of benefits and risks","volume":"118","author":"Ghaemi","year":"2008","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2023.103480_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1419","article-title":"Clinical applications of transcranial magnetic stimulation in bipolar disorder","volume":"9","author":"Gold","year":"2019","journal-title":"Brain Behav."},{"key":"10.1016\/j.ajp.2023.103480_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1176\/appi.ajp.2008.08050746","article-title":"Manic symptoms during depressive episodes in 1,380 patients with bipolar disorder: findings from the STEP-BD","volume":"166","author":"Goldberg","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/0269881116636545","article-title":"Evidence-based guidelines for treating bipolar disorder: revised third edition recommendations from the British Association for Psychopharmacology","volume":"30","author":"Goodwin","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102549","article-title":"Prescription patterns in clinically stable patients with bipolar disorder: findings from the Bipolar Disorder Course and Outcome from India (BiD-CoIN) study","volume":"57","author":"Grover","year":"2021","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2023.103480_bib36","first-page":"57","article-title":"Efficacy of carbamazepine and its derivatives in the treatment of bipolar disorder","author":"Grunze","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.ajp.2023.103480_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/15622970902823202","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania","volume":"10","author":"Grunze","year":"2009","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/15622970903555881","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: update 2010 on the treatment of acute bipolar depression","volume":"11","author":"Grunze","year":"2010","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib39","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3109\/15622975.2013.770551","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder","volume":"14","author":"Grunze","year":"2013","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/15622975.2017.1384850","article-title":"The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: acute and long-term treatment of mixed states in bipolar disorder","volume":"19","author":"Grunze","year":"2018","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/15622975.2018.1557346","article-title":"WFSBP guidelines on how to grade treatment evidence for clinical guideline development","volume":"20","author":"Hasan","year":"2019","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib42","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40345-021-00230-8","article-title":"Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study","volume":"9","author":"Higuchi","year":"2021","journal-title":"Int J. Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib43","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.08m04895yel","article-title":"Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study","volume":"70","author":"Houston","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/acps.13346","article-title":"Lithium concentration and recurrence risk during maintenance treatment of bipolar disorder: Multicenter cohort and meta-analysis","volume":"144","author":"Hsu","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2023.103480_bib45","article-title":"Adjunctive antidepressants for the acute treatment of bipolar depression: a systematic review and meta-analysis","volume":"311","author":"Hu","year":"2022","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.ajp.2023.103480_bib46","first-page":"566","article-title":"Lamotrigine-related skin rashes in adults","volume":"18","author":"Huang","year":"2002","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"Suppl 1","key":"10.1016\/j.ajp.2023.103480_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000049260","article-title":"Clozapine as add-on medication in the maintenance treatment of bipolar and schizoaffective disorders. A case series","volume":"45","author":"Hummel","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ajp.2023.103480_bib48","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/2045125318804364","article-title":"Medication nonadherence in bipolar disorder: a narrative review","volume":"8","author":"Jawad","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/JCP.0000000000001317","article-title":"A systematic review on the efficacy of intravenous racemic ketamine for bipolar depression","volume":"41","author":"Joseph","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib50","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1080\/24750573.2018.1480082","article-title":"Assessing the treatment adherence and clinical correlates of low adherence among bipolar disorder outpatients: a cross-sectional study","volume":"29","author":"Karada\u011f","year":"2019","journal-title":"Psychiatry Clin. Psychopharmacol."},{"issue":"Suppl 5","key":"10.1016\/j.ajp.2023.103480_bib51","first-page":"9","article-title":"Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder","volume":"69","author":"Ketter","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib52","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41380-021-01334-4","article-title":"Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials","volume":"27","author":"Kishi","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jad.2015.06.059","article-title":"Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorder","volume":"190","author":"Landbloom","year":"2016","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jad.2022.09.018","article-title":"Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019","volume":"318","author":"Lin","year":"2022","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib55","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1176\/appi.ajp.2013.13070984","article-title":"Lurasidone monotherapy in the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib56","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.2013.13070985","article-title":"Lurasidone as adjunctive therapy with lithium or valproate for the treatment of bipolar I depression: a randomized, double-blind, placebo-controlled study","volume":"171","author":"Loebel","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2010.08.017","article-title":"Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques","volume":"132","author":"Loo","year":"2011","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib58","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1399-5618.2009.00761.x","article-title":"A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently","volume":"11","author":"Macfadden","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib59","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jad.2021.10.052","article-title":"Evaluating maintenance electroconvulsive therapy in Bipolar Disorders: 3-year mirror-image study","volume":"298","author":"Madero","year":"2022","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/bdi.13036","article-title":"The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary","volume":"22","author":"Malhi","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib61","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1471-244X-12-160","article-title":"Quetiapine monotherapy in acute phase for major depressive disorder: a meta-analysis of randomized, placebo-controlled trials","volume":"12","author":"Maneeton","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0165-0327(98)00110-4","article-title":"Use of topiramate, a new anti-epileptic as a mood stabilizer","volume":"50","author":"Marcotte","year":"1998","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1399-5618.2011.00898.x","article-title":"Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study","volume":"13","author":"Marcus","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib64","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1176\/appi.ajp.2021.21060653r","article-title":"Ketamine and esketamine for treatment-resistant depression: response to reus, mattes, and schatzberg","volume":"178","author":"McIntyre","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib65","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1399-5618.2009.00748.x","article-title":"A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states","volume":"11","author":"McIntyre","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jad.2009.12.028","article-title":"Asenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trial","volume":"122","author":"McIntyre","year":"2010","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib67","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4088\/JCP.14m09410","article-title":"Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial","volume":"76","author":"McIntyre","year":"2015","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib68","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.jad.2019.07.020","article-title":"Cariprazine for the treatment of bipolar mania with mixed features: a post hoc pooled analysis of 3 trials","volume":"257","author":"McIntyre","year":"2019","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib69","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(20)31544-0","article-title":"Bipolar disorders","volume":"396","author":"McIntyre","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajp.2023.103480_bib70","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1017\/S1092852919001287","article-title":"Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies","volume":"25","author":"McIntyre","year":"2020","journal-title":"CNS Spectr."},{"key":"10.1016\/j.ajp.2023.103480_bib71","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib72","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1176\/appi.ajp.2016.15091119","article-title":"Mixed depression in bipolar disorder: prevalence rate and clinical correlates during naturalistic follow-up in the stanley bipolar network","volume":"173","author":"Miller","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib73","first-page":"89","article-title":"Suboptimal treatment adherence in bipolar disorder: impact on clinical outcomes and functioning","volume":"7","author":"Montes","year":"2013","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/j.ajp.2023.103480_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.767629","article-title":"Domain-Based Functional Improvements in Bipolar Disorder After Interpersonal and Social Rhythm Therapy","volume":"13","author":"Moot","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib75","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/ajp.151.2.169","article-title":"Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience","volume":"151","author":"Mukherjee","year":"1994","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neubiorev.2018.05.015","article-title":"Efficacy and acceptability of non-invasive brain stimulation for the treatment of adult unipolar and bipolar depression: a systematic review and meta-analysis of randomised sham-controlled trials","volume":"92","author":"Mutz","year":"2018","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.ajp.2023.103480_bib77","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/bdi.12018","article-title":"Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study","volume":"14","author":"Nielsen","year":"2012","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib78","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2007.04.020","article-title":"Olanzapine versus lithium in the acute treatment of bipolar mania: a double-blind, randomized, controlled trial","volume":"105","author":"Niufan","year":"2008","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib79","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bdi.12027","article-title":"The association of the effect of lithium in the maintenance treatment of bipolar disorder with lithium plasma levels: a post hoc analysis of a double-blind study comparing switching to lithium or placebo in patients who responded to quetiapine (Trial 144)","volume":"15","author":"Nolen","year":"2013","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib80","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s40263-014-0197-8","article-title":"Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination\/augmentation therapy versus monotherapy","volume":"28","author":"Ogawa","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2023.103480_bib81","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib82","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2019.02.003","article-title":"Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: a systematic review","volume":"29","author":"Pacchiarotti","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034757","article-title":"A 6 week randomized double-blind placebo-controlled trial of ziprasidone for the acute depressive mixed state","volume":"7","author":"Patkar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ajp.2023.103480_bib84","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.4088\/JCP.v67n1112","article-title":"Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial","volume":"67","author":"Perlis","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib85","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4088\/JCP.09m05514yel","article-title":"Clinical features associated with poor pharmacologic adherence in bipolar disorder: results from the STEP-BD study","volume":"71","author":"Perlis","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000328943","article-title":"Continuation and maintenance electroconvulsive therapy for mood disorders: review of the literature","volume":"64","author":"Petrides","year":"2011","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ajp.2023.103480_bib87","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40345-017-0075-7","article-title":"Long-term use of lurasidone in patients with bipolar disorder: safety and effectiveness over 2 years of treatment","volume":"5","author":"Pikalov","year":"2017","journal-title":"Int J. Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib88","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","article-title":"Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline","volume":"189","author":"Post","year":"2006","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib89","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1742-1241.1995.tb10004.x","article-title":"Low-dose maintenance clozapine treatment in the prophylaxis of bipolar affective disorder","volume":"49","author":"Puri","year":"1995","journal-title":"Br. J. Clin. Pr."},{"key":"10.1016\/j.ajp.2023.103480_bib90","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1177\/0004867419826718","article-title":"Prescribing practices of Indian psychiatrists in the treatment of bipolar disorder","volume":"53","author":"Reddy","year":"2019","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"Suppl 1","key":"10.1016\/j.ajp.2023.103480_bib91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000068020","article-title":"Initial lithium and valproate combination therapy in acute mania","volume":"46","author":"Reischies","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ajp.2023.103480_bib92","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1055\/s-2002-36392","article-title":"Initial triple therapy of acute mania, adding lithium and valproate to neuroleptics","volume":"35","author":"Reischies","year":"2002","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib93","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.psychres.2015.10.032","article-title":"Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression","volume":"230","author":"Romeo","year":"2015","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.ajp.2023.103480_bib94","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.4088\/JCP.v67n1105","article-title":"Adjunctive topiramate therapy in patients receiving a mood stabilizer for bipolar I disorder: a randomized, placebo-controlled trial","volume":"67","author":"Roy Chengappa","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib95","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib96","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(00)00991-4","article-title":"Bipolar disorder therapeutics: maintenance treatment","volume":"48","author":"Sachs","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib97","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jad.2014.11.018","article-title":"Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial","volume":"174","author":"Sachs","year":"2015","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib98","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jad.2014.05.015","article-title":"Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: a randomized double blind placebo controlled clinical trial","volume":"166","author":"Sahraian","year":"2014","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib99","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bdi.12959","article-title":"Pharmacological management of bipolar disorder: Japanese expert consensus","volume":"22","author":"Sakurai","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib100","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2165\/11203840-000000000-00000","article-title":"Quetiapine: a review of its use in the management of bipolar depression","volume":"26","author":"Sanford","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajp.2023.103480_bib101","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/YCT.0000000000000253","article-title":"Maintenance electroconvulsive therapy in severe bipolar disorder: a retrospective chart review","volume":"32","author":"Santos Pina","year":"2016","journal-title":"J. ECT"},{"key":"10.1016\/j.ajp.2023.103480_bib102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/appi.ajp.2014.13111517","article-title":"Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment","volume":"172","author":"Schoeyen","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib103","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0033-1363258","article-title":"Treatments for acute bipolar depression: meta-analyses of placebo-controlled, monotherapy trials of anticonvulsants, lithium and antipsychotics","volume":"47","author":"Selle","year":"2014","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib104","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1399-5618.2007.00475.x","article-title":"What is the optimal serum lithium level in the long-term treatment of bipolar disorder--a review?","volume":"10","author":"Severus","year":"2008","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/mpr.1773","article-title":"The prevalence and diagnostic classification of mixed features in patients with major depressive episodes: A multicenter study based on the DSM-5","volume":"28","author":"Shim","year":"2019","journal-title":"Int J. Methods Psychiatr. Res."},{"key":"10.1016\/j.ajp.2023.103480_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102935","article-title":"Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey","volume":"67","author":"Shinozaki","year":"2022","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.ajp.2023.103480_bib107","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1192\/bjp.164.6.806","article-title":"Combined chlorpromazine and electroconvulsive therapy in mania","volume":"164","author":"Sikdar","year":"1994","journal-title":"Br. J. Psychiatry.: J. Ment. Sci."},{"key":"10.1016\/j.ajp.2023.103480_bib108","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/bdi.13129","article-title":"Ketamine for treatment-resistant bipolar depression-need for more data!","volume":"23","author":"Singh","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib109","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1176\/ajp.156.8.1164","article-title":"Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania","volume":"156","author":"Suppes","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1176\/appi.ajp.2008.08020189","article-title":"Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127)","volume":"166","author":"Suppes","year":"2009","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jad.2013.02.031","article-title":"First controlled treatment trial of bipolar II hypomania with mixed symptoms: quetiapine versus placebo","volume":"150","author":"Suppes","year":"2013","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib112","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpsychires.2016.03.012","article-title":"Lurasidone adjunctive with lithium or valproate for bipolar depression: a placebo-controlled trial utilizing prospective and retrospective enrolment cohorts","volume":"78","author":"Suppes","year":"2016","journal-title":"J. Psychiatr. Res"},{"issue":"Suppl 1","key":"10.1016\/j.ajp.2023.103480_bib113","first-page":"7","article-title":"Long-term treatment in bipolar disorder","volume":"66","author":"Swann","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib114","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archpsyc.1997.01830130041008","article-title":"Depression during mania. Treatment response to lithium or divalproex","volume":"54","author":"Swann","year":"1997","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1192\/bjp.184.4.337","article-title":"Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone","volume":"184","author":"Tohen","year":"2004","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib116","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jad.2014.04.003","article-title":"Efficacy of olanzapine monotherapy in the treatment of bipolar depression with mixed features","volume":"164","author":"Tohen","year":"2014","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib117","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jad.2014.06.039","article-title":"Efficacy of olanzapine in the treatment of bipolar mania with mixed features defined by DSM-5","volume":"168","author":"Tohen","year":"2014","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib118","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12888-020-02967-5","article-title":"Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder","volume":"20","author":"Tokumitsu","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib119","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/acps.13055","article-title":"Pramipexole in the treatment of unipolar and bipolar depression. A systematic review and meta-analysis","volume":"140","author":"Tundo","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.ajp.2023.103480_bib120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1440-1819.2009.02042.x","article-title":"Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death","volume":"64","author":"Tural","year":"2010","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.ajp.2023.103480_bib121","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jad.2019.01.003","article-title":"Risperidone adjunctive therapy duration in the maintenance treatment of bipolar I disorder: a post hoc analysis","volume":"246","author":"Valdes","year":"2019","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib122","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1399-5618.2011.00887.x","article-title":"Long-term outcome of bipolar depressed patients receiving lamotrigine as add-on to lithium with the possibility of the addition of paroxetine in nonresponders: a randomized, placebo-controlled trial with a novel design","volume":"13","author":"van der Loos","year":"2011","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib123","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1176\/appi.ajp.2014.14070826","article-title":"Antidepressants in bipolar I disorder: never as monotherapy","volume":"171","author":"Vieta","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib124","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00004714-200208000-00017","article-title":"Use of topiramate in treatment-resistant bipolar spectrum disorders","volume":"22","author":"Vieta","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib125","doi-asserted-by":"crossref","first-page":"473","DOI":"10.4088\/JCP.v67n0320","article-title":"A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder","volume":"67","author":"Vieta","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib126","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1017\/S1461145708008596","article-title":"A double-blind, randomized, placebo-controlled prophylaxis trial of oxcarbazepine as adjunctive treatment to lithium in the long-term treatment of bipolar I and II disorder","volume":"11","author":"Vieta","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib127","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2008.06.001","article-title":"Efficacy and safety of quetiapine in combination with lithium or divalproex for maintenance of patients with bipolar I disorder (international trial 126)","volume":"109","author":"Vieta","year":"2008","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib128","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1176\/appi.ajp.2008.07101560","article-title":"Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate\/lithium monotherapy: a placebo-controlled study","volume":"165","author":"Vieta","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib129","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-5618.2010.00815.x","article-title":"A randomized, placebo- and active-controlled study of paliperidone extended release for the treatment of acute manic and mixed episodes of bipolar I disorder","volume":"12","author":"Vieta","year":"2010","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2012.04.014","article-title":"Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder","volume":"142","author":"Vieta","year":"2012","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib131","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/bdi.12860","article-title":"The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on bipolar depression","volume":"22","author":"Wang","year":"2020","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib132","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.4088\/JCP.11m06878","article-title":"Continuation of quetiapine versus switching to placebo or lithium for maintenance treatment of bipolar I disorder (Trial 144: a randomized controlled study)","volume":"72","author":"Weisler","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib133","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.1996.03540040037030","article-title":"Cross-national epidemiology of major depression and bipolar disorder","volume":"276","author":"Weissman","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.ajp.2023.103480_bib134","first-page":"1037","article-title":"Factors influencing the incidence of lamotrigine-related skin rash","volume":"33","author":"Wong","year":"1999","journal-title":"Ann. Pharm."},{"key":"10.1016\/j.ajp.2023.103480_bib135","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/hup.1240","article-title":"Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial","volume":"26","author":"Woo","year":"2011","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.ajp.2023.103480_bib136","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11126-014-9319-1","article-title":"Antipsychotic medication-induced dysphoria: its meaning, association with typical vs. atypical medications and impact on adherence","volume":"86","author":"Wu","year":"2015","journal-title":"Psychiatr. Q"},{"key":"10.1016\/j.ajp.2023.103480_bib137","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/mp.2015.158","article-title":"Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: a CANMAT randomized double-blind trial","volume":"21","author":"Yatham","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib138","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder","volume":"20","author":"Yatham","year":"2018","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib139","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/bdi.13135","article-title":"Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations","volume":"23","author":"Yatham","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.ajp.2023.103480_bib140","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1017\/S0033291714001305","article-title":"A network meta-analysis on comparative efficacy and all-cause discontinuation of antimanic treatments in acute bipolar mania","volume":"45","author":"Yildiz","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.ajp.2023.103480_bib141","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2018.33.e290","article-title":"Antidepressant prescription patterns in bipolar disorder: a nationwide, register-based study in Korea","volume":"33","author":"Yoon","year":"2018","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.ajp.2023.103480_bib142","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1176\/appi.ajp.161.1.169","article-title":"Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients","volume":"161","author":"Zarate","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib143","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4088\/JCP.v61n0307","article-title":"Clinical predictors of acute response with quetiapine in psychotic mood disorders","volume":"61","author":"Zarate","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.ajp.2023.103480_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2021.114019","article-title":"Efficacy and safety of electroconvulsive therapy plus medication versus medication alone in acute mania: a meta-analysis of randomized controlled trials","volume":"302","author":"Zhang","year":"2021","journal-title":"Psychiatry Res."}],"updated-by":[{"DOI":"10.1016\/j.ajp.2023.103537","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000}}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201823000345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1876201823000345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T00:24:06Z","timestamp":1717028646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1876201823000345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":144,"alternative-id":["S1876201823000345"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2023.103480","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.ajp.2023.103537","asserted-by":"object"}]},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Taiwan consensus on biological treatment of bipolar disorder during the acute, maintenance, and mixed phases: The 2022 update","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2023.103480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103480"}}